Top Medical News
Nearly half of atrial fibrillation (AF) patients on vitamin K antagonist (VKA) with prior time in therapeutic range (TTR) ≥70 percent had TTR <70 percent during the following year, reports a recent study. Additionally, there is limited long-term prognostic value for prior TTR ≥70 percent.
Isolated or combined blood pressure (BP) elevations identified by office or ambulatory measurements are associated with a greater risk of new-onset metabolic syndrome (MetS), suggests a recent study. On the other hand, only white-coat hypertension (WCH) is linked to an increased risk of incident MetS whenever BP phenotypes are identified by office or home measurement.
Tristan Manalac, Yesterday
Stroke is relatively more common in Singapore compared with other Asian countries, according to a recent study.
2 days ago
Acute coronary syndrome (ACS) patients with prasugrel contraindications tend to have worse in-hospital and postdischarge prognosis, according to a recent study, which reports that ticagrelor may be an effective alternative.
Pearl Toh, 2 days ago
Lifestyle interventions incorporating diet and exercise slash the need for antihypertensive medications by more than half among overweight or obese adults with high blood pressure (BP), according to a secondary analysis of the ENCORE trial presented at the Joint Hypertension 2018 Scientific Sessions.
2 days ago
Epicardial relative to endocardial left atrial appendage exclusion (LAAE) significantly reduces systolic blood pressure (SBP) in patients with atrial fibrillation (AF) and hypertension both at 3 and 12 months, according to a study.
2 days ago
A significant association exists between fluoroquinolone exposure and aortic aneurysm and dissection (AA/AD), suggests a recent study. Duration of fluoroquinolone use and length of the hazard period modify this risk.
Special Reports
01 Sep 2018
Ischaemic heart disease was the principal cause of death in Malaysia in 2016, and ST-segment elevation myocardial infarction (STEMI) is noted as the deadliest clinical presentation of Acute Coronary Syndrome. At the National Heart Association of Malaysia’s 2018 Annual Scientific Meeting, Professor Dr Wan Azman Wan Ahmad shared his insights into the management of STEMI in Malaysia, highlighting the implications of the recent TREAT trial.
31 May 2018
At the recent ‘Reinforced for the Glycaemic Challenge’ symposium held at Shangri-la Hotel, Kuala Lumpur, Associate Professor Dr Alexander Tan, Professor Dr Chee Kok Han and Dr Chan Siew Pheng shared their insights into the importance of achieving glycaemic control in patients with type 2 diabetes mellitus (T2DM), while simultaneously providing them with cardiovascular protection.
01 May 2018
CoQ10 isn't as popular as vitamin C or B in our daily lives but it's time to have a closer look at this vital nutrient.
30 Apr 2018
In this issue of MIMS Cardiology Supplement, we bring you clinical updates related to combating hypercholesterolaemia, highlighting the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in lowering low-density lipoprotein-cholesterol levels. 
12 Apr 2018
Home blood pressure monitoring (HBPM) is increasingly being recognized as an accurate adjunct to clinic blood pressure measurement for the diagnosis and management of hypertension. We discussed the HOPE Asia Network’s recently published consensus recommendations on HBPM with lead author, Prof. Sungha Park.

Click here to view the interview video with one of the authors - Professor Sungha Park
12 Apr 2018
In an effort to better understand hypertension subtypes – including morning and white-coat hypertension – in Asian patients, the HOPE Asia Network has initiated the Asia BP@Home study across 12 countries and regions. We discussed the study’s design and objectives with lead investigator, Prof. Kazuomi Kario.

Click here to view the interview video with lead investigator - Professor Kazuomi Kario
01 Mar 2018
At a cardiology conference held in Hilton Kuala Lumpur, senior consultant cardiologist Dato’ Sri Dr Azhari Rosman spoke on the importance of non–high-density lipoprotein cholesterol (non–HDL-C) and combination therapy as a novel approach in the management of atherogenic dyslipidemia (AD).
Conference Reports
Christina Lau, 10 Sep 2018

Very early invasive coronary angiography within 12 hours does not significantly improve long-term outcomes of patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) compared with the standard strategy of evaluation within 48–72 hours, according to results of the VERDICT trial reported at the European Society of Cardiology (ESC) Congress 2018.

Christina Lau, 07 Sep 2018

In patients with left-sided infective endocarditis in stable condition, switching to oral antibiotics is as effective and safe as continued treatment with intravenous (IV) antibiotics, according to results of the POET trial reported at the European Society of Cardiology (ESC) Congress 2018.

Christina Lau, 07 Sep 2018

Treatment with rivaroxaban for 45 days after hospital discharge reduces symptomatic venous thromboembolism (VTE), but not VTE-related mortality, in medically ill patients, results of the MARINER trial have shown.

Christina Lau, 06 Sep 2018
Extending ticagrelor therapy to 2 years with aspirin given for only 1 month after percutaneous coronary intervention (PCI) is not superior to standard treatment, according to results of the GLOBAL LEADERS trial reported at the European Society of Cardiology (ESC) Congress 2018.
Dr. Joseph Delano Fule Robles, 04 Sep 2018

The use of high-sensitivity cardiac troponin assays was not associated with a lower subsequent incidence of myocardial infarction (MI) or cardiovascular death at 1 year, according to results of the High-STEACS trial reported at the European Society of Cardiology (ESC) Congress 2018.

Christina Lau, 03 Sep 2018

The new 2018 European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines for the management of arterial hypertension recommend starting treatment for most patients with a two-in-one pill containing an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) in combination with a calcium channel blocker (CCB) or diuretic.

Jackey Suen, 03 Sep 2018

Percutaneous mitral-valve repair with MitraClip failed to improve clinical outcomes in chronic heart failure (HF) patients with severe secondary mitral regurgitation, according to the MITRA-FR study presented at the European Society of Cardiology (ESC) Congress 2018.

Product Highlights
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download